Functional Outcome After Minimally Invasive Pyeloplasty for Adult Patients With UPJO
Functional Outcome After Laparoscopic and Robot Assisted Management of Uretero-pelvic Junction Obstruction Disease Caused by Crossing Vessels for Adult Patients
1 other identifier
interventional
17
1 country
1
Brief Summary
an intervention study on adult patients with uretero-pelvic junction obstruction (UPJO) due to crossing vessels would be managed either through classic dismembered pyeloplasty or vascular hitch.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2023
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedFirst Posted
Study publicly available on registry
June 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedJune 9, 2023
May 1, 2023
2 years
May 31, 2023
June 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
comparing the two techniques regarding the success rate
both techniques are supposed to have similar results
2 years
Study Arms (2)
vascular hitch
EXPERIMENTALdisplacement of the lower polar crossing vessels causing the UPJO
Dismembered pyeloplasty
ACTIVE COMPARATORclassic Anderson-Hynes procedure
Interventions
Eligibility Criteria
You may qualify if:
- all patients with UPJO above 18 years
- UPJO caused by crossing vessels confirmed by CT angiography
- Symptomatic UPJO
You may not qualify if:
- recurrent UPJO after a previous trial of open repair ,
- secondary UPJO after open renal surgery.
- UPJO in non functioning kidney
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Medicine
Cairo, 115, Egypt
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- one blind
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of urology- faculty of medicine
Study Record Dates
First Submitted
May 31, 2023
First Posted
June 8, 2023
Study Start
June 1, 2023
Primary Completion
June 1, 2025
Study Completion
July 1, 2025
Last Updated
June 9, 2023
Record last verified: 2023-05